These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 8263888

  • 1. Prevalence of left ventricular hypertrophy as assessed by electrocardiogram in treated hypertensive persons in general practice.
    van den Hoogen JP, van Kruijsdijk MC, van Ree JW, Mokkink HG, Thien T, van Weel C.
    J Hum Hypertens; 1993 Oct; 7(5):473-7. PubMed ID: 8263888
    [Abstract] [Full Text] [Related]

  • 2. Prevalence of left ventricular hypertrophy detected by Cornell voltage-duration product in a hypertensive population.
    Barrios V, Escobar C, Calderon A, Ribas L, Marti D, Asin E.
    Blood Press; 2008 Oct; 17(2):110-5. PubMed ID: 18568700
    [Abstract] [Full Text] [Related]

  • 3. Prevalence of left ventricular hypertrophy in Finnish primary health care hypertensive patients.
    Kumpusalo E, Lappi J, Miettinen H, Takala J.
    J Hum Hypertens; 2001 Apr; 15(4):255-8. PubMed ID: 11319673
    [Abstract] [Full Text] [Related]

  • 4. Ambulatory 24-hour blood pressure monitoring: correlation between blood pressure variability and left ventricular hypertrophy in untreated hypertensive patients.
    Feola M, Boffano GM, Procopio M, Reynaud S, Allemano P, Rizzi G.
    G Ital Cardiol; 1998 Jan; 28(1):38-44. PubMed ID: 9493044
    [Abstract] [Full Text] [Related]

  • 5. Trends in hypertension control and left ventricular hypertrophy over three years.
    Cuspidi C, Michey I, Meani S, Severgnini B, Fusi V, Salerno M, Valerio C, Magrini F, Zanchetti A.
    Ital Heart J; 2002 Sep; 3(9):514-9. PubMed ID: 12407847
    [Abstract] [Full Text] [Related]

  • 6. Relation of electrocardiographic left ventricular hypertrophy to blood pressure, body mass index, serum lipids and blood sugar levels in adult Nigerians.
    Opadijo OG, Omotoso AB, Akande AA.
    Afr J Med Med Sci; 2003 Dec; 32(4):395-9. PubMed ID: 15259925
    [Abstract] [Full Text] [Related]

  • 7. Electrocardiographic characteristics and metabolic risk factors associated with inappropriately high left ventricular mass in patients with electrocardiographic left ventricular hypertrophy: the LIFE Study.
    Palmieri V, Okin PM, de Simone G, Bella JN, Wachtell K, Gerdts E, Boman K, Nieminen MS, Dahlöf B, Devereux RB.
    J Hypertens; 2007 May; 25(5):1079-85. PubMed ID: 17414673
    [Abstract] [Full Text] [Related]

  • 8. [Left ventricular hypertrophy in the Spanish hypertensive population. The ERIC-HTA study].
    Lozano JV, Redón J, Cea-Calvo L, Fernández-Pérez C, Navarro J, Bonet A, González-Esteban J.
    Rev Esp Cardiol; 2006 Feb; 59(2):136-42. PubMed ID: 16540035
    [Abstract] [Full Text] [Related]

  • 9. Clinical correlates of left ventricular mass in elderly hypertensives.
    James MA, Fotherby MD, Potter JF.
    J Hum Hypertens; 1994 Jun; 8(6):409-15. PubMed ID: 8089825
    [Abstract] [Full Text] [Related]

  • 10. [Left ventricular hypertrophy among hypertensive patients with diminished glomerular filtration rate].
    Grabysa R, Cholewa M.
    Pol Merkur Lekarski; 2008 Oct; 25(148):309-14. PubMed ID: 19145927
    [Abstract] [Full Text] [Related]

  • 11. Left ventricular hypertrophy in hypertensive patients in Indian primary care: prevalence and effect of treatment with sustained release indapamide.
    Lokhandwala Y, Damle A.
    Curr Med Res Opin; 2004 May; 20(5):639-44. PubMed ID: 15140328
    [Abstract] [Full Text] [Related]

  • 12. Signal averaged ECG in different patterns of left ventricular hypertrophy and geometry in hypertension.
    Wojszwiłło A, Łoboz-Grudzień K, Jaroch J.
    Kardiol Pol; 2003 May; 58(5):335-43. PubMed ID: 14523481
    [Abstract] [Full Text] [Related]

  • 13. Prevalence and predictors of left ventricular hypertrophy in patients with hypertension and normal electrocardiogram.
    Nardi E, Palermo A, Mulè G, Cusimano P, Cerasola G, Rini GB.
    Eur J Prev Cardiol; 2013 Oct; 20(5):854-61. PubMed ID: 22556375
    [Abstract] [Full Text] [Related]

  • 14. Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study.
    Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Nieminen MS, Snapinn S, Harris KE, Aurup P, Edelman JM, Dahlof B, Losartan Intervention for Endpoint reduction in hypertension Study Investigations.
    Circulation; 2003 Aug 12; 108(6):684-90. PubMed ID: 12885747
    [Abstract] [Full Text] [Related]

  • 15. Impact of diabetes mellitus on regression of electrocardiographic left ventricular hypertrophy and the prediction of outcome during antihypertensive therapy: the Losartan Intervention For Endpoint (LIFE) Reduction in Hypertension Study.
    Okin PM, Devereux RB, Gerdts E, Snapinn SM, Harris KE, Jern S, Kjeldsen SE, Julius S, Edelman JM, Lindholm LH, Dahlöf B, LIFE Study Investigators.
    Circulation; 2006 Mar 28; 113(12):1588-96. PubMed ID: 16534012
    [Abstract] [Full Text] [Related]

  • 16. Prevalence and determinants of electrocardiographic left ventricular hypertrophy among a multiethnic population of postmenopausal women (The Women's Health Initiative).
    Oberman A, Prineas RJ, Larson JC, LaCroix A, Lasser NL.
    Am J Cardiol; 2006 Feb 15; 97(4):512-9. PubMed ID: 16461048
    [Abstract] [Full Text] [Related]

  • 17. Left ventricular hypertrophy and heart failure in women.
    Agabiti-Rosei E, Muiesan ML.
    J Hypertens Suppl; 2002 May 15; 20(2):S34-8. PubMed ID: 12183849
    [Abstract] [Full Text] [Related]

  • 18. Prevalence of electrocardiographic left ventricular hypertrophy in human hypertension: an updated review.
    Cuspidi C, Rescaldani M, Sala C, Negri F, Grassi G, Mancia G.
    J Hypertens; 2012 Nov 15; 30(11):2066-73. PubMed ID: 22914541
    [Abstract] [Full Text] [Related]

  • 19. Electrocardiographic left ventricular hypertrophy and arterial stiffness: the Ohasama study.
    Watabe D, Hashimoto J, Hatanaka R, Hanazawa T, Ohba H, Ohkubo T, Kikuya M, Totsune K, Imai Y.
    Am J Hypertens; 2006 Dec 15; 19(12):1199-205. PubMed ID: 17161763
    [Abstract] [Full Text] [Related]

  • 20. Randomized study of traditional versus aggressive systolic blood pressure control (Cardio-Sis): rationale, design and characteristics of the study population.
    Cardio-Sis Study Group.
    J Hum Hypertens; 2008 Apr 15; 22(4):243-51. PubMed ID: 18046432
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.